Gyre Therapeutics Gets China's Approval For Tablets For Thrombocytopenia Treatment
2/7 22:54
(RTTNews) - Gyre Therapeutics (GYRE), a commercial-stage biotechnology company with clinical development programs focusing on a variety of chronic organ diseases, Tuesday announced that China's National Medical Products Administration has approved Gyre Pharmaceuticals' avatrombop...